{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:33:21Z","timestamp":1793338401076,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.drudis.2022.103468","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:50:10Z","timestamp":1671018610000},"page":"103468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Medicinal chemistry insights into antiviral peptidomimetics"],"prefix":"10.1016","volume":"28","author":[{"given":"Dang","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeildo Ferreira","family":"da Silva-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2022.103468_b0005","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/v12020138","article-title":"Smallpox in the post-eradication era","volume":"12","author":"Meyer","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2022.103468_b0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/590567","article-title":"The 1918 \u2018Spanish flu\u2019 in Spain","volume":"47","author":"Trilla","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2022.103468_b0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The biology of the HIV-1 latent reservoir and implications for cure strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2022.103468_b0020","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","article-title":"Emerging pandemic diseases: how we got to COVID-19","volume":"182","author":"Morens","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2022.103468_b0025","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1039\/D0CS01084G","article-title":"Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses","volume":"50","author":"Ma","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drudis.2022.103468_b0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2022.103468_b0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","article-title":"Peptidomimetic therapeutics: scientific approaches and opportunities","volume":"22","author":"Qvit","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"27","key":"10.1016\/j.drudis.2022.103468_b0040","first-page":"1075","article-title":"The pharmaceutical industry in 2021. An analysis of FDA drug approvals from the perspective of molecules","volume":"2022","author":"Torre","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2022.103468_b0045","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1021\/acs.jmedchem.2c00123","article-title":"Peptidomimetics: an overview of recent medicinal chemistry efforts toward the discovery of novel small molecule inhibitors","volume":"65","author":"Li Petri","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0050","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1039\/D0CS00102C","article-title":"Peptidomimetic toolbox for drug discovery","volume":"49","author":"Lenci","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drudis.2022.103468_b0055","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1002\/anie.201412070","article-title":"Structure-based design of inhibitors of protein-protein interactions: mimicking peptide binding epitopes","volume":"54","author":"Pelay-Gimeno","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.drudis.2022.103468_b0060","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1039\/D1CS01175H","article-title":"Synthetic helical peptide capping strategies","volume":"51","author":"Whisenant","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drudis.2022.103468_b0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1039\/D0CS00344A","article-title":"Photocatalytic methods for amino acid modification","volume":"50","author":"King","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drudis.2022.103468_b0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","article-title":"Direct anti-HCV agents","volume":"6","author":"Zhang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drudis.2022.103468_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/acs.jmedchem.5b00825","article-title":"A journey around the medicinal chemistry of hepatitis C virus inhibitors targeting NS4B: from target to preclinical drug candidates","volume":"59","author":"Cannalire","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide-boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0085","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1039\/c3cs60384a","article-title":"Peptidomimetics via modifications of amino acids and peptide bonds","volume":"43","author":"Avan","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.drudis.2022.103468_b0090","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres: strategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0095","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.3390\/molecules26102937","article-title":"1,2,3-triazoles as biomimetics in peptide science","volume":"26","author":"Agouram","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2022.103468_b0100","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0105","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.1021\/jm5010896","article-title":"Peptides containing \u03b2-amino acid patterns: challenges and successes in medicinal chemistry","volume":"57","author":"Cabrele","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0110","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1021\/cr400355w","article-title":"Cellular incorporation of unnatural amino acids and bioorthogonal labeling of proteins","volume":"114","author":"Lang","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drudis.2022.103468_b0115","doi-asserted-by":"crossref","first-page":"10807","DOI":"10.1021\/acs.jmedchem.6b00319","article-title":"Unusual amino acids in medicinal chemistry","volume":"59","author":"Blaskovich","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0120","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/138161210793292555","article-title":"Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization","volume":"16","author":"Gentilucci","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2022.103468_b0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40265-020-01284-1","article-title":"Advances in long-acting agents for the treatment of HIV infection","volume":"80","author":"Rana","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2022.103468_b0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.034","article-title":"Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study","volume":"85","author":"Su","year":"2022","journal-title":"J. Infect."},{"key":"10.1016\/j.drudis.2022.103468_b0135","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.3390\/ijms22168677","article-title":"Recent applications of retro-inverso peptides","volume":"22","author":"Doti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drudis.2022.103468_b0140","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/molecules27051646","article-title":"The effects of side-chain configurations of a retro-inverso-type inhibitor on the human T-cell leukemia virus (HTLV)-1 protease","volume":"27","author":"Awahara","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2022.103468_b0145","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1021\/acs.jmedchem.6b01029","article-title":"Side chain cyclized aromatic amino acids: great tools as local constraints in peptide and peptidomimetic design","volume":"59","author":"Van der Poorten","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0150","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1021\/acs.chemrev.8b00744","article-title":"Multicomponent reaction toolbox for peptide macrocyclization and stapling","volume":"119","author":"Reguera","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drudis.2022.103468_b0155","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1039\/C8SC05474F","article-title":"Macrocyclisation of small peptides enabled by oxetane incorporation","volume":"10","author":"Roesner","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.drudis.2022.103468_b0160","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1021\/jm401507s","article-title":"Discovery and development of simeprevir (TMC435), a HCV NS3\/4A protease inhibitor","volume":"57","author":"Rosenquist","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0165","doi-asserted-by":"crossref","first-page":"11972","DOI":"10.1021\/acs.jmedchem.1c00554","article-title":"Discovery of quinoxaline-based P1\u2013P3 macrocyclic NS3\/4A protease inhibitors with potent activity against drug-resistant hepatitis C virus variants","volume":"64","author":"Nageswara","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0170","doi-asserted-by":"crossref","first-page":"18932","DOI":"10.1021\/jacs.1c07013","article-title":"Suprastapled peptides: hybridization-enhanced peptide ligation and enforced \u03b1-helical conformation for affinity selection of combinatorial libraries","volume":"143","author":"Sabale","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2022.103468_b0175","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1021\/acs.jmedchem.5b00073","article-title":"Peptide triazole inactivators of HIV-1 utilize a conserved two-cavity binding site at the junction of the inner and outer domains of env gp120","volume":"58","author":"Aneja","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2022.103468_b0185","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJMra2035343","article-title":"Maintaining safety with SARS-CoV-2 vaccines","volume":"384","author":"Castells","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2022.103468_b0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2022.103468_b0195","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.103468_b0200","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.103468_b0205","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","article-title":"Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19","volume":"63","author":"Hoffman","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0210","doi-asserted-by":"crossref","first-page":"e01819","DOI":"10.1128\/JVI.01819-20","article-title":"A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19","volume":"95","author":"de Vries","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2022.103468_b0215","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0220","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.103468_b0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acscentsci.2c00369","article-title":"The path to Paxlovid","volume":"8","author":"Halford","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.drudis.2022.103468_b0230","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40265-022-01692-5","article-title":"Nirmatrelvir plus Ritonavir: first approval","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2022.103468_b0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2022.103468_b0240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drudis.2022.103468_b0245","doi-asserted-by":"crossref","first-page":"eabn7842","DOI":"10.1126\/scitranslmed.abn7842","article-title":"Antibodies elicited by SARS-CoV\u20132 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses","volume":"14","author":"Sievers","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2022.103468_b0250","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12967-020-02476-9","article-title":"A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host\u2013directed antivirals","volume":"18","author":"Chitalia","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drudis.2022.103468_b0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2022.103468_b0260","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.abg6837","article-title":"SARS-CoV-2 dependence on host pathways","volume":"371","author":"Wong","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.103468_b0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drudis.2022.103468_b0270","doi-asserted-by":"crossref","first-page":"e1009225","DOI":"10.1371\/journal.ppat.1009225","article-title":"SARS-CoV\u20132 tropism, entry, replication, and propagation: considerations for drug discovery and development","volume":"17","author":"Murgolo","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2022.103468_b0275","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","article-title":"A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic","volume":"605","author":"Shapira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2022.103468_b0280","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrmicro3503","article-title":"HIV-1 capsid: the multifaceted key player in HIV-1 infection","volume":"13","author":"Campbell","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2022.103468_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113380","article-title":"An insight on medicinal aspects of novel HIV\u20131 capsid protein inhibitors","volume":"217","author":"Sun","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0290","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/acs.jmedchem.0c00015","article-title":"Design, synthesis, and mechanism study of benzenesulfonamide-containing phenylalanine derivatives as novel HIV-1 capsid inhibitors with improved antiviral activities","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0295","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1021\/acs.jmedchem.1c02022","article-title":"Design and evaluation of a novel peptide-drug conjugate covalently targeting SARS-CoV-2 papain-like protease","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0300","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.drudis.2022.103468_b0305","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/17460441.2019.1614910","article-title":"Recent applications of click chemistry in drug discovery","volume":"14","author":"Jiang","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.drudis.2022.103468_b0310","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drudis.2015.08.004","article-title":"Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries","volume":"21","author":"Wang","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2022.103468_b0315","doi-asserted-by":"crossref","first-page":"14585","DOI":"10.1002\/chem.202002250","article-title":"Protein-templated hit identification through an ugi four-component reaction","volume":"26","author":"Mancini","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.drudis.2022.103468_b0320","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1021\/acs.jmedchem.0c00483","article-title":"Late-stage lead diversification coupled with quantitative nuclear magnetic resonance spectroscopy to identify new structure-activity relationship vectors at nanomole-scale synthesis: application to loratadine, a human histamine H1 receptor inverse agonist","volume":"63","author":"Lall","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2022.103468_b0325","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1021\/acs.jmedchem.9b00359","article-title":"Overview of recent strategic advances in medicinal chemistry","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622004615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622004615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:09Z","timestamp":1761224529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644622004615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1359644622004615"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103468","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medicinal chemistry insights into antiviral peptidomimetics","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103468"}}